These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33051990)

  • 41. A longitudinal prospective study of cytomegalovirus pp65 antigenemia in renal transplant recipients.
    Bein G; Bitsch A; Hoyer J; Steinhoff J; Fricke L; Machnik H; Dennin R; Kirchner H
    Transpl Int; 1993; 6(4):185-90. PubMed ID: 8394089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
    Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study.
    Boeckh M; Gooley TA; Myerson D; Cunningham T; Schoch G; Bowden RA
    Blood; 1996 Nov; 88(10):4063-71. PubMed ID: 8916975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients.
    Humar A; Gregson D; Caliendo AM; McGeer A; Malkan G; Krajden M; Corey P; Greig P; Walmsley S; Levy G; Mazzulli T
    Transplantation; 1999 Nov; 68(9):1305-11. PubMed ID: 10573068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prognosis value of the pp65 antigenemia and semi-quantitative PCR in the detection of the CMV reactivation in bone marrow grafted patients].
    Ksouri H; Lakhal A; Ben Amor R; Torjman L; Achour W; Ben Othmen T; Ladeb S; Abdelkefi A; Slim A; Abdeladhim A; Ben Hassen A
    Bull Soc Pathol Exot; 2006 Jul; 99(3):155-9. PubMed ID: 16983816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence and clinical features of cytomegalovirus infection diagnosed by cytomegalovirus pp65 antigenemia assay during high dose corticosteroid therapy for collagen vascular diseases.
    Yamashita M; Ishii T; Iwama N; Takahashi H
    Clin Exp Rheumatol; 2006; 24(6):649-55. PubMed ID: 17207380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis.
    Kim JW; Boo SJ; Ye BD; Kim CL; Yang SK; Kim J; Kim SA; Park SH; Park SK; Yang DH; Jung KW; Kim KJ; Byeon JS; Myung SJ; Kim JH
    J Crohns Colitis; 2014 Jul; 8(7):693-701. PubMed ID: 24405983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
    Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
    Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
    Boeckh M; Huang M; Ferrenberg J; Stevens-Ayers T; Stensland L; Nichols WG; Corey L
    J Clin Microbiol; 2004 Mar; 42(3):1142-8. PubMed ID: 15004066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytomegalovirus (CMV) Monitoring After Liver Transplantation: Comparison of CMV Pp65 Antigenemia Assay with Real-Time PCR Calibrated to WHO International Standard.
    Kamei H; Ito Y; Onishi Y; Suzuki M; Imai H; Kurata N; Hori T; Tainaka T; Uchida H; Ogura Y
    Ann Transplant; 2016 Mar; 21():131-6. PubMed ID: 26927444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for cytomegalovirus disease with cytomegalovirus re-activation in patients with rheumatic disease.
    Kaneshita S; Kida T; Yokota I; Nagahara H; Seno T; Wada M; Kohno M; Kawahito Y
    Mod Rheumatol; 2020 Jan; 30(1):109-115. PubMed ID: 30472908
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytomegalovirus Pneumonia in Patients with Rheumatic Diseases After Immunosuppressive Therapy: A Single Center Study in China.
    Xue Y; Jiang L; Wan WG; Chen YM; Zhang J; Zhang ZC
    Chin Med J (Engl); 2016 Feb; 129(3):267-73. PubMed ID: 26831226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.
    Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients.
    Kusne S; Grossi P; Irish W; St George K; Rinaldo C; Rakela J; Fung J
    Transplantation; 1999 Oct; 68(8):1125-31. PubMed ID: 10551640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytomegalovirus antigenemia.
    The TH; van der Bij W; van den Berg AP; van der Giessen M; Weits J; Sprenger HG; van Son WJ
    Rev Infect Dis; 1990; 12 Suppl 7():S734-44. PubMed ID: 2173103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequential cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies.
    Ozaki KS; Pestana JO; Granato CF; Pacheco-Silva A; Camargo LF
    Transpl Infect Dis; 2004 Jun; 6(2):63-8. PubMed ID: 15522106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality.
    Bacigalupo A; Tedone E; Isaza A; Soracco M; Van Lint MT; Sanna A; Frassoni F; Occhini D; Gualandi F; Lamparelli T
    Bone Marrow Transplant; 1995 Jul; 16(1):155-61. PubMed ID: 7581116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of cytomegalovirus antigenemia and culture assays in patients on and off antiviral therapy.
    St George K; Rinaldo CR
    J Med Virol; 1999 Sep; 59(1):91-7. PubMed ID: 10440814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antigenemia and real time polymerase chain reaction for diagnosis of cytomegalovirus disease in HIV infected adults].
    Luchsinger V; Vásquez P; Silva M; Bruno MJ; Siches I; Villarroel J; Garmendia ML; Larrañaga C
    Rev Chilena Infectol; 2015 Dec; 32(6):664-71. PubMed ID: 26928503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.